Dextromethorphan Polistirex Patent Expiration
Dextromethorphan Polistirex is used for treating a variety of conditions such as depression, anxiety, and panic disorders. It was first introduced by Rb Health Us Llc
Dextromethorphan Polistirex Patents
Given below is the list of patents protecting Dextromethorphan Polistirex, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Delsym | US5980882 | Drug-resin complexes stabilized by chelating agents |
Apr 16, 2017
(Expired) | Rb Hlth |
Dextromethorphan Polistirex's Family Patents
Explore Our Curated Drug Screens
Dextromethorphan Polistirex Generic API Manufacturers
Several generic applications have been filed for Dextromethorphan Polistirex. The first generic version for Dextromethorphan Polistirex was by Tris Pharma Inc and was approved on May 25, 2012. And the latest generic version is by Amneal Pharmaceuticals Llc and was approved on Jul 28, 2017.
Given below is the list of companies who have filed for Dextromethorphan Polistirex generic, along with the locations of their manufacturing plants worldwide.
1. AMNEAL
Amneal Pharmaceuticals Llc has filed for 1 generic for Dextromethorphan Polistirex. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 30MG HYDROBROMIDE/5ML | suspension, extended release | Over the counter | ORAL | N/A | Jul 28, 2017 |
Manufacturing Plant Locations New
Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
2. TRIS PHARMA INC
Tris Pharma Inc has filed for 1 generic for Dextromethorphan Polistirex. Given below are the details of the strengths of this generic introduced by Tris Pharma Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 30MG HYDROBROMIDE/5ML | suspension, extended release | Over the counter | ORAL | N/A | May 25, 2012 |
Manufacturing Plant Locations New
Tris Pharma Inc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Tris Pharma Inc as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||